Club news:
2022 – Oh what a year! 2022 was a productive and promising year for Alzheimer’s research, including discoveries related to the causes, risk factors and treatment of Alzheimer’s disease and other dementias. Here are 5 important things we learned about Alzheimer’s in 2022: • Alzheimer’s treatments are getting better In November, pharmaceutical companies Eisai and Biogen announced positive results from their global Phase 3 clinical trial of an Alzheimer’s drug called lecanemab, slowing the rate of cognitive decline in study participants by 28% over 18 months.